METELIMUMAB
UNII 4AR6718OL0

Substance Identification & Data

This profile provides standardized clinical and technical data for Metelimumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4AR6718OL0.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 272780-74-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4AR6718OL0

CAS Registry Number

272780-74-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

METELIMUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166745

National Cancer Institute reference terminology for clinical and research data.

INN ID

8087

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Metelimumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

METELIMUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4, ANTI-(HUMAN TRANSFORMING GROWTH FACTOR .BETA.1 (HUMAN MONOCLONAL CAT-192 .GAMMA.4-CHAIN)), DISULFIDE WITH HUMAN MONOCLONAL CAT-192 .KAPPA.-CHAIN, DIMER

METELIMUMAB [INN]

METELIMUMAB [WHO-DD]